Federal Loan Policy Is Pricing Women Out of Healthcare’s Most Critical Roles
The July 1 changes are being framed as student loan policy. But they raise a larger question about what kind of labor, and whose labor, America is willing to invest in.
The July 1 changes are being framed as student loan policy. But they raise a larger question about what kind of labor, and whose labor, America is willing to invest in.
We aren't killing the problem that fax created. We are migrating it into a format that carries a higher expectation of automated processing — without yet having solved the underlying challenge that made automation hard in the first place.
For seniors, the change in policy will dramatically expand access to a revolutionary medication. But there are also significant risks.
This is not an abstract discussion. It is about sustaining the organizations, employees, and communities that depend on us. If we fail to account for how these policies interact in the real world, we risk weakening the very system we are trying to improve.
Today’s adjustment offers insight into what the next phase of the program is focusing on and will subsequently reward, and why this moment matters, especially for newer and regional plans.
Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products.
An algorithm can flag an irregular heartbeat. But it cannot notice that Tom hasn't mentioned his late wife in two weeks, or that he's wearing the same shirt for the fourth day running. Those observations require a person in the room, not a sensor on the wall.
For consumers and clinicians the difference between “FDA-cleared,” “FDA-registered,” and general wellness products is not always obvious. Clear communication about intended use and supporting evidence is essential for maintaining trust.
Technology alone won’t solve prior authorization. But refusing to adopt it guarantees the status quo: a system where insurers operate at machine speed, providers operate at human speed, and patients pay the price in delayed care.
A proposed amendment to existing legislation could create centralized and harmonized rules for single-use device reprocessing across all EU member countries.
Caregivers are a backbone of serious illness care, but they cannot carry the system alone. We have reached a point where failing to support them is indistinguishable from failing patients.
In today's dynamic environment, companies are navigating deal-making and innovation spurred by the vertical integration of AI and a rebounding IPO market. Here are ten global trends poised to define the industry in the coming year.
There is no question the pressures are heavy, but there is also an opportunity for organizations to rethink how they deliver care, how they support the people they serve, and how they invest limited resources.
We should never wait for tragedies to force a conversation around clear governance and accountability. Oversight has to evolve alongside innovation to protect people before harm occurs.
Health plans are being asked to adapt quickly, to reconfigure technology, reimagine operations, and anticipate ripple effects that stretch across claims, member engagement, compliance, and workforce strategy.